NCT00257179

Brief Summary

This study uses serum tissue factor and tissue factor inhibitor and factor VII to monitor the pre-coagulation status in lung cancer patients and to correlate the pre-coagulation status with clinical staging and prognosis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2005

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 22, 2005

Completed
Last Updated

March 14, 2006

Status Verified

June 1, 2005

First QC Date

November 21, 2005

Last Update Submit

March 13, 2006

Conditions

Lung Cancer

Keywords

Tissue factorLung cancerTissue factor protein inhibitorFactor VIIFactor X

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with newly-diagnosed lung cancer
  • Serum from cancer-free healthy volunteers

You may not qualify if:

  • Chronic renal failure or end-stage renal disease \[ESRD\] (creatinine \[Cr\] \> 2 )
  • Hyperlipidemia on statin therapy
  • Acute myocardial infarction
  • Tapal or Plavix use
  • Active thromboembolic event
  • Severe liver disease (\> child B)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Chong-Jen Yu, M.D., Ph.D.

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chong-Jen Yu, M.D., Ph.D.

CONTACT

886-2-2356-2905jeffery@ha.mc.ntuh.edu.tw

Study Design

Study Type
observational
Observational Model
NATURAL HISTORY
Time Perspective
OTHER
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 21, 2005

First Posted

November 22, 2005

Study Start

June 1, 2005

Last Updated

March 14, 2006

Record last verified: 2005-06

Locations

TW(1)